Compound information
- Natural Products
- ZC877462
- Molecular Formula
- C11H14Cl2N2O3S
- Molecular Weight
- 324.010218668 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-chloro-N-[4-chloro-3-(dimethylsulfamoyl)phenyl]propanamide
- InChI
- InChI=1S/C11H14Cl2N2O3S/c1-7(12)11(16)14-8-4-5-9(13)10(6-8)19(17,18)15(2)3/h4-7H,1-3H3,(H,14,16)/t7-/m1/s1
- InChI Key
- MAUYFAOQAKMIGP-SSDOTTSWSA-N
- SMILES
- C[C@@H](Cl)C(=O)Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1
- Source
- ZINC000008855848
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 2.282 |
LogS | -3.607 | LogD | 2.347 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.096 | Pgp substrate | 0.152 |
HIA | 0.967 | F20 % | 0.991 |
F30 % | 0.978 | Caco-2 | -4.913 |
MDCK | -4.559 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.056 | PPB | 96.202 |
VD | 1.551 | Fu | 1.015 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.977 | CYP1A2 substrate | 0.679 |
CYP2A6 substrate | 0.747 | CYP2B6 substrate | 0.65 |
CYP2C19 inhibitor | 0.733 | CYP2C19 substrate | 0.902 |
CYP2C8 substrate | 0.848 | CYP2C9 inhibitor | 0.749 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.309 |
CYP2D6 substrate | 0.942 | CYP2E1 substrate | 0.983 |
CYP3A4 inhibitor | 0.831 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.318 | CL | 10.592 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.062 | Hepatotoxicity | 0.947 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.051 |
FDAMDD | 0.157 | Skin Sensitization | 0.758 |
Carcinogenicity | 0.069 | Eye Corrosion | 0.027 |
Eye Irritation | 0.017 | Respiratory Toxicity | 0.857 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.436 | IGC50 | 4.141 |
LC50FM | 4.742 | LC50DM | 4.46 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.15 | NR-AR-LBD | 0.323 |
NR-AhR | 0.299 | NR-Aromatase | 0.88 |
NR-ER | 0.289 | NR-ER-LBD | 0.38 |
NR-PPAR-gamma | 0.387 | SR-ARE | 0.75 |
SR-ATAD5 | 0.418 | SR-HSE | 0.129 |
SR-MMP | 0.118 | SR-p53 | 0.314 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.